Affordable Access

deepdyve-link
Publisher Website

Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact.

Authors
  • Cantini, Fabrizio1
  • Niccoli, Laura2
  • Matarrese, Daniela3
  • Nicastri, Emanuele4
  • Stobbione, Paolo5
  • Goletti, Delia6
  • 1 Rheumatology Department, Azienda USL Toscana Centro, Hospital of Prato, Piazza Ospedale 1. Electronic address: [email protected]
  • 2 Rheumatology Department, Azienda USL Toscana Centro, Hospital of Prato, Piazza Ospedale 1.
  • 3 Azienda USL Toscana Centro, Hospital of Prato, Italy. Electronic address: [email protected] , (Italy)
  • 4 National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Via Portuense, 292, Rome 00149, Italy. Electronic address: [email protected] , (Italy)
  • 5 AOS Antonio e Biagio e C. Arrigo, Rheumatology Unit - Alessandria, Italy. Electronic address: [email protected] , (Italy)
  • 6 National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Via Portuense, 292, Rome 00149, Italy; Department of Epidemiology and Preclinical Research, "L. Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS, Via Portuense 292, 00149 Rome, Italy. Electronic address: [email protected] , (Italy)
Type
Published Article
Journal
The Journal of infection
Publication Date
Aug 01, 2020
Volume
81
Issue
2
Pages
318–356
Identifiers
DOI: 10.1016/j.jinf.2020.04.017
PMID: 32333918
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times